Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-11-02

FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva's supplemental application for Claravis (isotretinoin). This document announces the approval of a supplemental submission for this acne medica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Claravis (isotretinoin)

Snippet

SUPPL AP for CLARAVIS (ISOTRETINOIN)